SCHEMBL30436740

SCHEMBL30436740

Cc1cc(C(=O)Nc2cc(NC(=O)c3ccc4cn[nH]c4c3)ccc2C)no1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 7/20 0.56
▸ MAP4K4 O95819 1/20 0.54
▸ CLK2 P49760 1/20 0.54
▸ DYRK1A Q13627 1/20 0.54
▸ SRPK1 Q96SB4 1/20 0.54
▸ CLK4 Q9HAZ1 1/20 0.54
▸ NPC1 O15118 3/20 0.51
▸ MAPT P10636 3/20 0.51
▸ RAB9A P51151 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ CSF1R P07333 7/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51
▸ DDR2 Q16832 1/20 0.49
▸ LYN P07948 1/20 0.48
▸ KIT P10721 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25224059 1.00 MAOB (0.56) MAOBMAP4K4CLK2DYRK1ASRPK1
SCHEMBL25536494 0.89 MAOB (0.52) MAOBMAP4K4CLK2DYRK1ASRPK1
SCHEMBL30435799 0.82 CSF1R (0.50) NPC1MAPTRAB9ASMN1; SMN2CSF1R
SCHEMBL25232996 0.82 CSF1R (0.50) NPC1MAPTRAB9ASMN1; SMN2CSF1R
SCHEMBL30436723 0.77 CSF1R (0.60) NPC1MAPTRAB9ASMN1; SMN2CSF1R
SCHEMBL25239044 0.77 CSF1R (0.60) NPC1MAPTRAB9ASMN1; SMN2CSF1R
SCHEMBL25232229 0.77 ALDH1A1 (0.55) NPC1RAB9ASMN1; SMN2CSF1RALDH1A1
SCHEMBL30436982 0.77 ALDH1A1 (0.55) NPC1RAB9ASMN1; SMN2CSF1RALDH1A1
SCHEMBL1752546 0.74 MAPK14 (0.71) MAOB
SCHEMBL25245214 0.74 RAB9A (0.66) NPC1MAPTRAB9ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023096304-A1 ISOXAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF 한양대학교 에리카산학협력단 2023-06-01 — — WO claimed
WO-2023096304-A1 ISOXAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF 한양대학교 에리카산학협력단 2023-06-01 — — WO disclosed
Send feedback